Sulphadoxine and pyrimethamine as treatment for acute Plasmodium falciparum malaria.
D000208:Acute Disease; D002738:Chloroquine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D008887:Military Medicine; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*
D011743:Pyrimidines; D013449:Sulfonamides; D002738:Chloroquine; D011739:Pyrimethamine